Nevro Gross Margin 2013-2023 | NVRO
Current and historical gross margin for Nevro (NVRO) over the last 10 years. The current gross profit margin for Nevro as of December 31, 2023 is %.
| Nevro Gross Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM Gross Profit | Gross Margin |
| 2023-12-31 | $0.43B | $0.29B | 68.24% |
| 2023-09-30 | $0.42B | $0.28B | 67.14% |
| 2023-06-30 | $0.42B | $0.28B | 67.54% |
| 2023-03-31 | $0.41B | $0.28B | 68.12% |
| 2022-12-31 | $0.41B | $0.28B | 67.98% |
| 2022-09-30 | $0.40B | $0.27B | 68.35% |
| 2022-06-30 | $0.39B | $0.27B | 68.56% |
| 2022-03-31 | $0.39B | $0.26B | 68.13% |
| 2021-12-31 | $0.39B | $0.27B | 68.73% |
| 2021-09-30 | $0.39B | $0.28B | 69.80% |
| 2021-06-30 | $0.41B | $0.29B | 69.93% |
| 2021-03-31 | $0.36B | $0.25B | 69.15% |
| 2020-12-31 | $0.36B | $0.25B | 69.25% |
| 2020-09-30 | $0.37B | $0.25B | 69.32% |
| 2020-06-30 | $0.36B | $0.25B | 69.19% |
| 2020-03-31 | $0.40B | $0.28B | 69.87% |
| 2019-12-31 | $0.39B | $0.27B | 68.72% |
| 2019-09-30 | $0.38B | $0.26B | 68.49% |
| 2019-06-30 | $0.38B | $0.26B | 68.42% |
| 2019-03-31 | $0.38B | $0.26B | 69.11% |
| 2018-12-31 | $0.39B | $0.27B | 70.36% |
| 2018-09-30 | $0.38B | $0.27B | 70.63% |
| 2018-06-30 | $0.36B | $0.26B | 70.88% |
| 2018-03-31 | $0.35B | $0.24B | 70.52% |
| 2017-12-31 | $0.33B | $0.23B | 69.94% |
| 2017-09-30 | $0.30B | $0.21B | 69.23% |
| 2017-06-30 | $0.28B | $0.19B | 68.71% |
| 2017-03-31 | $0.26B | $0.17B | 68.24% |
| 2016-12-31 | $0.23B | $0.15B | 67.25% |
| 2016-09-30 | $0.19B | $0.13B | 65.45% |
| 2016-06-30 | $0.15B | $0.09B | 63.45% |
| 2016-03-31 | $0.10B | $0.06B | 60.40% |
| 2015-12-31 | $0.07B | $0.04B | 59.42% |
| 2015-09-30 | $0.05B | $0.03B | 60.87% |
| 2015-06-30 | $0.04B | $0.03B | 62.50% |
| 2015-03-31 | $0.04B | $0.02B | 64.86% |
| 2014-12-31 | $0.03B | $0.02B | 64.71% |
| 2014-06-30 | $0.02B | $0.01B | 61.90% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $0.443B | $0.425B |
| Nevro Corp. is a medical device company which engages in developing and commercializing a neuromodulation platform for the treatment of chronic pain, primarily in the leg. The company is known for developing and commercializing the Senza spinal cord stimulation (SCS) system, an evidence-based neuromodulation platform for the treatment of chronic pain. Additionally, the company's HF10 therapy provides long-lasting relief from chronic back and leg pain. Nevro's flagship Senza SCS system has been consistently driving the top line. Since its commercial launch in the United States, the system raked in significant revenues. These apart, Senza is commercially available in Europe since 2010 and in Australia since 2011. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Thermo Fisher Scientific (TMO) | United States | $207.950B | 25.29 |
| Intuitive Surgical (ISRG) | United States | $129.849B | 78.28 |
| Edwards Lifesciences (EW) | United States | $51.730B | 34.24 |
| DexCom (DXCM) | United States | $50.391B | 86.56 |
| IQVIA Holdings (IQV) | United States | $41.398B | 24.55 |
| IDEXX Laboratories (IDXX) | United States | $39.563B | 47.30 |
| Alcon (ALC) | Switzerland | $39.226B | 28.93 |
| STERIS (STE) | Ireland | $19.714B | 23.33 |
| Hologic (HOLX) | United States | $17.694B | 19.53 |
| Waters (WAT) | United States | $17.562B | 25.20 |
| SONOVA HOLDING (SONVY) | Switzerland | $16.183B | 0.00 |
| ShockWave Medical (SWAV) | United States | $12.304B | 85.01 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $11.467B | 14.16 |
| Teleflex (TFX) | United States | $9.729B | 15.28 |
| Sysmex ADR (SSMXY) | Japan | $9.453B | 29.65 |
| Penumbra (PEN) | United States | $7.846B | 97.00 |
| Masimo (MASI) | United States | $7.131B | 39.99 |
| Globus Medical (GMED) | United States | $6.816B | 21.61 |
| Glaukos (GKOS) | United States | $4.843B | 0.00 |
| Integer Holdings (ITGR) | United States | $3.907B | 24.97 |
| LivaNova (LIVN) | United Kingdom | $2.824B | 18.62 |
| TransMedics (TMDX) | United States | $2.753B | 0.00 |
| Elekta AB (EKTAY) | Sweden | $2.581B | 17.71 |
| PROCEPT BioRobotics (PRCT) | United States | $2.558B | 0.00 |
| Nihon Kohden (NHNKY) | Japan | $2.327B | 19.68 |
| Integra LifeSciences Holdings (IART) | United States | $2.254B | 9.25 |
| Inari Medical (NARI) | United States | $2.237B | 385.90 |
| Tandem Diabetes Care (TNDM) | United States | $1.965B | 0.00 |
| RxSight (RXST) | United States | $1.908B | 0.00 |
| Alphatec Holdings (ATEC) | United States | $1.730B | 0.00 |
| Veracyte (VCYT) | United States | $1.460B | 0.00 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.864B | 15.99 |
| OPKO Health (OPK) | United States | $0.857B | 0.00 |
| Artivion (AORT) | United States | $0.825B | 95.38 |
| Paragon 28 (FNA) | United States | $0.812B | 0.00 |
| OrthoPediatrics (KIDS) | United States | $0.721B | 0.00 |
| Silk Road Medical (SILK) | United States | $0.679B | 0.00 |
| Treace Medical Concepts (TMCI) | United States | $0.677B | 0.00 |
| SiBone (SIBN) | United States | $0.633B | 0.00 |
| Mesa Laboratories (MLAB) | United States | $0.543B | 18.45 |
| IRadimed (IRMD) | United States | $0.519B | 30.15 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.490B | 0.00 |
| Pacific Biosciences Of California (PACB) | United States | $0.415B | 0.00 |
| Pulse Biosciences (PLSE) | United States | $0.397B | 0.00 |
| NeuroPace (NPCE) | United States | $0.367B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.342B | 11.52 |
| CVRx (CVRX) | United States | $0.322B | 0.00 |
| AxoGen (AXGN) | United States | $0.284B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.269B | 0.00 |
| Sight Sciences (SGHT) | United States | $0.254B | 0.00 |
| AngioDynamics (ANGO) | United States | $0.251B | 0.00 |
| Accuray (ARAY) | United States | $0.212B | 0.00 |
| 908 Devices (MASS) | United States | $0.184B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.181B | 9.75 |
| Alpha Tau Medical (DRTS) | Israel | $0.178B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.172B | 0.00 |
| Inogen (INGN) | United States | $0.159B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.144B | 0.00 |
| Delcath Systems (DCTH) | United States | $0.124B | 0.00 |
| Neuronetics (STIM) | United States | $0.114B | 0.00 |
| Yubo Biotech (YBGJ) | China | $0.112B | 0.00 |
| Envoy Medical (COCH) | United States | $0.099B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.095B | 0.00 |
| Spectral Diagnostics (EDTXF) | Canada | $0.086B | 0.00 |
| Monogram Orthopaedics (MGRM) | United States | $0.071B | 0.00 |
| EnVVeno Medical (NVNO) | United States | $0.062B | 0.00 |
| Hyperfine (HYPR) | United States | $0.060B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.056B | 0.00 |
| Vasomedical (VASO) | United States | $0.055B | 9.83 |
| Sensus Healthcare (SRTS) | United States | $0.054B | 109.67 |
| Vicarious Surgical (RBOT) | United States | $0.051B | 0.00 |
| InspireMD (NSPR) | Israel | $0.049B | 0.00 |
| SEP Acquisition (SEPA) | United States | $0.049B | 0.00 |
| Aspira Women's Health (AWH) | United States | $0.043B | 0.00 |
| ReWalk Robotics (LFWD) | Israel | $0.041B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.038B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.038B | 0.00 |
| Pixie Dust Technologies (PXDT) | Japan | $0.037B | 0.00 |
| LENSAR (LNSR) | United States | $0.037B | 0.00 |
| DarioHealth (DRIO) | United States | $0.034B | 0.00 |
| Precision Optics (POCI) | United States | $0.033B | 0.00 |
| Spectral AI (MDAI) | United States | $0.032B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.024B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.023B | 0.00 |
| Accelerate Diagnostics (AXDX) | United States | $0.019B | 0.00 |
| QT Imaging Holdings (QTI) | United States | $0.018B | 0.00 |
| PAVmed (PAVM) | United States | $0.017B | 0.00 |
| T2 Biosystems (TTOO) | United States | $0.016B | 0.00 |
| Biosig Technologies (BSGM) | United States | $0.016B | 0.00 |
| NexGel (NXGL) | United States | $0.014B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.013B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.012B | 0.00 |
| Avinger (AVGR) | United States | $0.006B | 0.00 |
| Venus Concept (VERO) | Canada | $0.005B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.005B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.003B | 0.00 |
| Tenon Medical (TNON) | United States | $0.003B | 0.00 |
| Dynatronics (DYNT) | United States | $0.003B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.002B | 0.00 |
| ReShape Lifesciences (RSLS) | United States | $0.002B | 0.00 |
| Nuwellis (NUWE) | United States | $0.002B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.001B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.001B | 0.00 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |